Abstract
The effect of a single whole-blood transfusion on the cascade of cytokine secretion was studied in patients with chronic renal failure. The results indicate that 1 week after blood transfusion, no significant changes were observed in the secretion of interleukin-2, colony-stimulating factor, tumor necrosis factor, and γ-interferon. However, 2 weeks after blood transfusion, a sharp decrease was observed in the generation of these cytokines. A decrease of about 70% was observed in interleukin-2, tumor necrosis factor, and γ-interferon secretion. The production of colony-stimulating factor 2 weeks after blood transfusion amounted to about 30% less than baseline levels. No statistical differences in interleukin-1 production were observed throughout the study. In addition, we found that the decrease in cytokine secretion was paralleled by a sharp increase in thein vitro secretion of prostaglandin E2. Thus the beneficial effect of blood transfusion on graft survival might be due in part to an immunosuppressive effect brought about by immuno-regulatory changes via the cascade of cytokine secretion.
Similar content being viewed by others
References
Opelz G, Sengar DPS, Mickey MR, Terasaki PI: Effect of blood transfusions on subsequent kidneys transplants. Transplant Proc 5:253–259, 1973
Brent L, Horsburgh T, Wood PJ: Induction of suppressor cells and allograft tolerance. Transplant Proc 12:464–467, 1980
Singal DP, Joseph S: Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients. Hum Immunol 4:93–108, 1982
Lenhard V, Massen G, Seifert P, Johannsen R, Grosse-Wilde H: Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients. Transplant Proc 14:329–332, 1982
Burlingham WJ, Sparks-Mackety EMF, Wendel T, Pan MH, Sondel PM, Sollinger HW: Beneficial effect of pretransplant donor-specific transfusions: Evidence for an idiotype network mechanism. Transplant Proc 17:2376–2378, 1985
Terasaki PI: The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 37:119–125, 1984
Jane Shelby M, Marushack M, Nelson EW: Prostaglandin production and suppressor cell induction in transfusion-induced immune suppression. Transplantation 43(1):113–116, 1987
Strom TB, Tilney NL, Paradysz JM, Bancewicz J, Carpenter CB: Cellular components of allograft rejection: Identity, specificity and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol 118:2020–2027, 1977
Farrar JJ, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J: The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev 63:129–166, 1982
Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G: Inhibition of Interferon-gama may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 220:176–179, 1985
Kirkman RL, Barrell LV, Gaulton GN: The effect of antiinterleukin-2 receptor monoclonal antibody on allograft rejection. Transplantation 40:719–722, 1985
Moy J, Rosenau W: Demonstration of alpha-lymphotoxin in human rejected renal allografts. Clin Immunol Immunopathol 20:49–56, 1981
Vie H, Bonneville M, Cariou R, Moreau JF, Soulillou JP: Interleukin-2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes. Kidney Int 28:553–557, 1985
Claesson K, Ronnblom L, Alm G, Tufveson G: Antiviral activity appearing in serum of renal transplant recipients—its possible relation to immunological rejection. Transplantation 38:32–34, 1984
Schot JDL, Schuurman RKB: Blood transfusion suppresses cutaneous cell-mediated immunity. Clin Exp Immunol 65:336–344, 1986
Pluznik DH, Sachs L: The induction of colonies of normal mast cells by a substance in conditional medium. Exp Cell Res 43:553–563, 1966
Wood ML, Gottschalk R, Monaco AP: Effect of blood transfusion on IL-1 production. Transplantation 45:930–935, 1988
Rabie NS, Kisala JM, Dean RE, Geha AS, Chaudry IH: Effect of blood transfusion on antigen presentation function and on IL-2 generation. Arch Surg 123:235–240, 1988
Lenhard V, Gemsa D, Opelz G: Transfusion-induced release of prostaglandin E2 and its role in the activation of T suppressor cells. Transplant Proc 17:2380–2382, 1985
Webb DR, Osheroff PL: Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci USA 73:1300–1304, 1976
Walker C, Kristensen F, Bettens F, de Weck AL: Lymphokine regulation of activated (G) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin-2 production. J Immunol 130:1770–1773, 1983
Goodwin FS: Modulation of concanavalin-A induced suppressor cell activation by prostaglandin E2. Cell Immunol 49:421–425, 1980
Bunjes D, Heit W, Arnold R: Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation 43:501–506, 1987
Kaplan J, Sarnaik S, Gitlin J: Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusion. Blood 64:308–310, 1984
Hefeneider SH, Conlon PJ, Henney CS: In vivo IL-2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol 130:222–227, 1983
Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ: Interleukin-2 mediated immune interferon (IFNγ) production by human T cells and T cell subsets. J Immunol 130:1983–1987, 1984
Johnson HM, Farrar WL: The role of gamma interferon-like lymphokine in the activation of T cells for expression of interleukin-2 receptors. Cell Immunol 75:154–159, 1983
Henney CS, Kuribayashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature 291:335–338, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalechman, Y., Gafter, U., Sobelman, D. et al. The effect of a single whole-blood transfusion on cytokine secretion. J Clin Immunol 10, 99–105 (1990). https://doi.org/10.1007/BF00918191
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918191